Firm Advises Top 5 Global Pharmaceutical Company on Unfair Competition and Public Tender

  • Dispute Resolution
  • Life Sciences

Marchenko Danevych advised one of the Top 5 Global pharmaceutical companies (Global 500 company) on the dispute resolution strategy to challenge unfair competition practices of a competing undertaking controlled by Ukrainian and U.S. investors, including the results of an annual public tender apparently procured through bribes and influence peddling.

We advised the Client to consider a combination of domestic unfair competition actions, U.S. FCPA and domestic anticorruption actions, and claims for damages.